GLP-1 receptor drugs and their effects on obstructive sleep apnea: a combined analysis of clinical trials

GLP-1 receptor agonists may improve outcomes for patients with moderate-to-severe obstructive sleep apnea.

• Weight reduction is advised for all overweight and obese individuals with obstructive sleep apnea.
• GLP-1 receptor agonists have shown clinical benefits in weight reduction.
• There is potential for these therapies to enhance outcomes related to obstructive sleep apnea.
• The analysis focuses on the efficacy and safety of GLP-1 receptor agonists in this patient group.

Simplified